BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3079792)

  • 1. Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity.
    Dillman RO; Johnson DE; Shawler DL
    J Immunol; 1986 Jan; 136(2):728-31. PubMed ID: 3079792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen.
    Schroff RW; Klein RA; Farrell MM; Stevenson HC
    J Immunol; 1984 Oct; 133(4):2270-7. PubMed ID: 6236264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
    Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
    Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
    Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
    J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies.
    Clement LT; Tilden AB; Dunlap NE
    J Immunol; 1985 Jul; 135(1):165-71. PubMed ID: 3923099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ; Hermes FF; Willems RW; Capel PJ; Koene RA
    J Immunol; 1984 Sep; 133(3):1185-9. PubMed ID: 6235283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
    J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of murine IgG subclass proteins with human monocyte Fc receptors.
    Lubeck MD; Steplewski Z; Baglia F; Klein MH; Dorrington KJ; Koprowski H
    J Immunol; 1985 Aug; 135(2):1299-304. PubMed ID: 3159790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
    Kurlander RJ
    J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients.
    Schroff RW; Farrell MM; Klein RA; Oldham RK; Foon KA
    J Immunol; 1984 Sep; 133(3):1641-8. PubMed ID: 6379051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
    J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC; Hargrove ME; Yun YS
    J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.
    Baiu DC; Prechl J; Tchorbanov A; Molina HD; Erdei A; Sulica A; Capel PJ; Hazenbos WL
    J Immunol; 1999 Mar; 162(6):3125-30. PubMed ID: 10092761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human K cells by surface antigens and morphology at the single cell level.
    Wåhlin B; Perlmann P
    J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.